Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy

被引:22
|
作者
Li, Yafeng [1 ]
Yu, Yinxi [2 ]
VanderBeek, Brian L. [1 ,3 ,4 ]
机构
[1] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Ctr Prevent Ophthalmol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Leonard Davis Inst, Perelman Sch Med, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
BILLING CODES; MACULAR EDEMA; VISUAL-LOSS; HYPOXIA; HEMOGLOBIN; ACCURACY; CARE;
D O I
10.1038/s41433-019-0617-6
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background/Aims To determine if anaemia and oxygen delivery-related co-morbidities (ODCs) affect progression from non-proliferative diabetic retinopathy (NPDR) to vision-threatening diabetic retinopathy (VTDR). Methods This is a retrospective cohort study using medical claims data from a large US insurer. Cohorts were created from all NPDR patients between 2002 and 2016. Primary exclusion criteria consisted of any previous diagnosis of proliferative diabetic retinopathy (PDR), diabetic macular oedema (DME) or treatment used in the care of VTDR. The main outcome was a new diagnosis of VTDR (DME or PDR), PDR, or DME. A time-dependent, multivariate Cox proportional hazard regression was used to determine the association between anaemia and other ODCs with NPDR progression. Results Of the total 69,982 NPDR patients included for analysis, 12,270, 2,162, and 10,322 progressed to VTDR, PDR and DME, respectively. Both mild and moderate/severe (mod/sev) anaemia were associated with an increased hazard for progression to VTDR (mild HR:1.10, 95% CI:1.04-1.16, p < 0.001; mod/sev HR:1.20, 95% CI:1.12-1.29, p < 0.001), PDR (mild HR:1.29, 95% CI:1.13-1.46, p < 0.001; mod/sev HR:1.43, 95% CI:1.21-1.69, p < 0.001), and DME (mild HR:1.06, 95% CI:1.00-1.13, p < 0.001; mod/sev HR:1.14, 95% CI:1.05-1.24, p < 0.001). ODCs such as chronic pulmonary disease and history of blood disorder/cancer were also significantly associated with an increased hazard for NPDR progression (HR > 1.00, p < 0.001 for all comparisons). Conclusions Anaemia, independent of kidney disease, appears to play a significant role in progression from NPDR to VTDR, PDR, or DME. Concurrently, association of ODCs with NPDR progression lends support to the underlying mechanisms of anaemia in the pathogenesis of diabetic retinopathy.
引用
收藏
页码:934 / 941
页数:8
相关论文
共 50 条
  • [31] Non-Proliferative Diabetic Retinopathy Detection Using Mathematical Morphology
    Mohamed, Bouacheria
    Abdelmalek, Benouadah
    Yazid, Cherfa
    Assia, Cherfa
    Nourreddine, Belkhamsa
    2018 IEEE 4TH MIDDLE EAST CONFERENCE ON BIOMEDICAL ENGINEERING (MECBME), 2018, : 219 - 224
  • [32] Deep Diagnosis of Non-Proliferative Diabetic Retinopathy in a Mobile System
    Dizdaroglu, Bekir
    Corbacioglu, Bilal
    2019 MEDICAL TECHNOLOGIES CONGRESS (TIPTEKNO), 2019, : 41 - 44
  • [33] Hierarchical severity grade classification of non-proliferative diabetic retinopathy
    Bhardwaj, Charu
    Jain, Shruti
    Sood, Meenakshi
    JOURNAL OF AMBIENT INTELLIGENCE AND HUMANIZED COMPUTING, 2021, 12 (02) : 2649 - 2670
  • [34] Oxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathy
    Daniel Rodriguez-Carrizalez, Adolfo
    Alberto Castellanos-Gonzalez, Jose
    Cesar Martinez-Romero, Esau
    Miller-Arrevillaga, Guillermo
    Villa-Hernandez, David
    Pablo Hernandez-Godinez, Pedro
    Gabriel Ortiz, Genaro
    Paul Pacheco-Moises, Fermin
    German Cardona-Munoz, Ernesto
    Guillermina Miranda-Diaz, Alejandra
    JOURNAL OF DIABETES, 2014, 6 (02) : 167 - 175
  • [35] Retinal vasculature–function correlation in non-proliferative diabetic retinopathy
    Yunkao Zeng
    Dan Cao
    Dawei Yang
    Xuenan Zhuang
    Yunyan Hu
    Miao He
    Honghua Yu
    Jun Wang
    Cheng Yang
    Liang Zhang
    Documenta Ophthalmologica, 2020, 140 : 129 - 138
  • [36] Fundus autofluorescence lifetimes are increased in non-proliferative diabetic retinopathy
    Schmidt, Johanna
    Peters, Sven
    Sauer, Lydia
    Schweitzer, Dietrich
    Klemm, Matthias
    Augsten, Regine
    Mueller, Nicolle
    Hammer, Martin
    ACTA OPHTHALMOLOGICA, 2017, 95 (01) : 33 - 40
  • [37] Efficacy and Safety of Etofibrate in Patients with Non-Proliferative Diabetic Retinopathy
    Emmerich, K. -H.
    Poritis, N.
    Stelmane, I.
    Klindzane, M.
    Erbler, H.
    Goldsteine, J.
    Goertelmeyer, R.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2009, 226 (07) : 561 - 567
  • [38] Electrodiagnostic and echographic evaluation of patients with non-proliferative diabetic retinopathy
    Mirza, SA
    Allie, A
    Good, PA
    Stavrou, P
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U111 - U111
  • [39] Pupillary light reflexes in non-proliferative diabetic retinopathy.
    McAnany, J. Jason
    Park, Jason C.
    Blair, Norman P.
    Chau, Felix Yan-Fay
    Lim, Jennifer I.
    Leiderman, Yannek Isaac
    Shahidi, Mahnaz
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [40] Hierarchical severity grade classification of non-proliferative diabetic retinopathy
    Charu Bhardwaj
    Shruti Jain
    Meenakshi Sood
    Journal of Ambient Intelligence and Humanized Computing, 2021, 12 : 2649 - 2670